101 related articles for article (PubMed ID: 2363856)
1. Augmentation of the effect of doxorubicin with low-dose tumor necrosis factor in experimental liver metastasis.
Bloom ND; Norbergs DA; Sherman B; Sadjadi M; Ramaswamy G; Jacobs R; Ackerman N
Mol Biother; 1990 Jun; 2(2):121-4. PubMed ID: 2363856
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of antitumor efficacy by the combination of recombinant tumor necrosis factor and chemotherapeutic agents in vivo.
Krosnick JA; Mulé JJ; McIntosh JK; Rosenberg SA
Cancer Res; 1989 Jul; 49(14):3729-33. PubMed ID: 2736513
[TBL] [Abstract][Full Text] [Related]
3. Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat.
Kooistra KL; Rodriguez M; Powis G
Cancer Res; 1989 Feb; 49(4):977-82. PubMed ID: 2912564
[TBL] [Abstract][Full Text] [Related]
4. Effect of low-dose tumor necrosis factor-alpha in combination with STEALTH liposomal cisplatin (SPI-077) on soft-tissue- and osteosarcoma-bearing rats.
Hoving S; van Tiel ST; Eggermont AM; ten Hagen TL
Anticancer Res; 2005; 25(2A):743-50. PubMed ID: 15868905
[TBL] [Abstract][Full Text] [Related]
5. Combination cytokine immunotherapy with tumor necrosis factor alpha, interleukin 2, and alpha-interferon and its synergistic antitumor effects in mice.
McIntosh JK; Mulé JJ; Krosnick JA; Rosenberg SA
Cancer Res; 1989 Mar; 49(6):1408-14. PubMed ID: 2784349
[TBL] [Abstract][Full Text] [Related]
6. Topical chemotherapy of intradermal Walker 256 carcinosarcoma with diaziquone and doxorubicin in the rat.
Moore DJ; Powis G; Richardson RL; Pittelkow MR
Cancer Res; 1985 Nov; 45(11 Pt 1):5466-72. PubMed ID: 4053022
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of tumor blood flow and tumoricidal effect of doxorubicin by intraportal epinephrine in experimental liver metastasis.
Bloom ND; Kroop E; Sadjadi M; Jacobs R; Ramaswamy G; Ackerman NB
Arch Surg; 1987 Nov; 122(11):1269-72. PubMed ID: 3675191
[TBL] [Abstract][Full Text] [Related]
8. [Intra-arterial infusion chemotherapy combine with noradrenalin administration (an improved antitumor effect using a cancerous blood vessel].
Sato T; Katsumi S; Murai T; Kawaguchi T
Gan To Kagaku Ryoho; 1985 Oct; 12(10):1915-21. PubMed ID: 3931558
[TBL] [Abstract][Full Text] [Related]
9. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.
Singh TR; Shankar S; Chen X; Asim M; Srivastava RK
Cancer Res; 2003 Sep; 63(17):5390-400. PubMed ID: 14500373
[TBL] [Abstract][Full Text] [Related]
10. Enhanced therapeutic effect against liver W256 carcinosarcoma with temperature-sensitive liposomal adriamycin administered into the hepatic artery.
Zou Y; Yamagishi M; Horikoshi I; Ueno M; Gu X; Perez-Soler R
Cancer Res; 1993 Jul; 53(13):3046-51. PubMed ID: 8319211
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms by which chemotherapeutic agents augment the antitumor effects of tumor necrosis factor: involvement of the pattern shift of cytokines from Th2 to Th1 in tumor lesions.
Inagawa H; Nishizawa T; Honda T; Nakamoto T; Takagi K; Soma G
Anticancer Res; 1998; 18(5D):3957-64. PubMed ID: 9854510
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.
Keane MM; Ettenberg SA; Nau MM; Russell EK; Lipkowitz S
Cancer Res; 1999 Feb; 59(3):734-41. PubMed ID: 9973225
[TBL] [Abstract][Full Text] [Related]
13. Target distribution of magnetic albumin nanoparticles containing adriamycin in transplanted rat liver cancer model.
Gong LS; Zhang YD; Liu S
Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):365-8. PubMed ID: 15313670
[TBL] [Abstract][Full Text] [Related]
14. [Influences of tumor necrosis factor-alpha on protein metabolism and cell-cycle kinetics in malignant tumor].
Ye SL; Tang ZY; Bistrian BR
Zhonghua Zhong Liu Za Zhi; 1994 Sep; 16(5):349-52. PubMed ID: 7895585
[TBL] [Abstract][Full Text] [Related]
15. Synergistic antitumor effects of immunotherapy with recombinant interleukin-2 and recombinant tumor necrosis factor-alpha.
McIntosh JK; Mulé JJ; Merino MJ; Rosenberg SA
Cancer Res; 1988 Jul; 48(14):4011-7. PubMed ID: 3260130
[TBL] [Abstract][Full Text] [Related]
16. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of recombinant human tumor necrosis factor in combination with hyperthermia, chemotherapy, or immunotherapy.
Haranaka K; Sakurai A; Satomi N
J Biol Response Mod; 1987 Aug; 6(4):379-91. PubMed ID: 3625230
[TBL] [Abstract][Full Text] [Related]
18. [Cytotoxicity of recombinant human tumor necrosis factor (rHTNF) alone and in combination with chemotherapeutic agents on human ovarian cancer cells].
Zhao EF
Zhonghua Fu Chan Ke Za Zhi; 1993 Mar; 28(3):153-6, 188. PubMed ID: 8354095
[TBL] [Abstract][Full Text] [Related]
19. Protection of multiple antioxidants Chinese herbal medicine on the oxidative stress induced by adriamycin chemotherapy.
Qin XJ; He W; Hai CX; Liang X; Liu R
J Appl Toxicol; 2008 Apr; 28(3):271-82. PubMed ID: 17582587
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effect of recombinant human tumor necrosis factor-alpha analog combined with desmuramyl dipeptides LK-409 or LK-410 on sarcoma in mice.
Sersa G; Novakovic S; Stalc A
Mol Biother; 1992 Dec; 4(4):188-92. PubMed ID: 1476673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
